CMND Clearmind Medicine Inc.
$5.85▲ +0.00%
Healthcare
Other
Volume 4.3K
Avg Volume (10D) 6.9K
Key Metrics & Fundamentals
Market Cap
$2.97M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.25 - 2688.00
% vs 50 MA
-28.96%
% vs 200 MA
-88.03%
RSI-14
36.3
MACD Histogram
+0.1500
Beta (1Y vs SPY)
-0.12
Free Cash Flow
-$2.71M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.39M
COGS
–
Operating Exp
$2.18M
Operating Income
-$2.18M
EBIT
-$2.18M
Pretax Income
-$904,061
Net Income
-$907,291
EPS (Diluted)
-0.57
Price & Volume History
Loading chart…
Recent News
Was The Run In Moderna Stock Hiding In Plain Sight?
Trefis · Oct 28, 2026 5:24 AM ET
Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial
GlobeNewswire · Oct 27, 2026 8:22 AM ET
How Much Downside Is Left In Moderna Stock?
Trefis · Oct 23, 2026 4:00 AM ET
What Is The Case For Waiting On Moderna Stock?
Trefis · Oct 16, 2026 10:44 AM ET
Where Could Moderna's Next Growth Come From?
Trefis · Oct 12, 2026 5:01 PM ET
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Oct 12, 2026 10:29 AM ET
Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets
GlobeNewswire · Oct 12, 2026 7:55 AM ET
Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder
GlobeNewswire · Oct 8, 2026 7:32 AM ET
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
GlobeNewswire · Oct 7, 2026 8:40 AM ET
NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration With Clearmind Covering LSD, Ketamine and Ibogaine Combinations
NewMediaWire · Sep 23, 2026 9:05 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CMND's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.